Abstract Heparin-induced thrombocytopenia (HIT), even rare, is a life-threatening, immune-
mediated complication of heparin exposure. It is considered the most severe non-bleeding …

Heparin-induced thrombocytopenia (HIT) occurs in approximately 3% of patients receiving
heparinoids. About 30–75% of patients with type 2 of HIT develop thrombosis as a result of …

Heparin-induced thrombocytopenia (HIT) is a recognized clinical entity in patients receiving
unfractionated heparin and low–molecular weight heparin. Currently, diagnosing HIT …

Thrombocytopenia is a common complication of critical care patients. The rates of bleeding
events and mortality are also significantly increased in critical care patients with …

Objectives: Describe the clinical presentation of heparin-induced thrombocytopenia. Explain
the potential complications of heparin-induced thrombocytopenia. Review the …

As COVID-19 vaccines became widely available, there have been reports of neurovascular
complications. In this article, we aim to report a case of cerebral venous sinus thrombosis …

ABSTRACT Introduction Fcγ-receptors (FcγR) are membrane receptors expressed on a
variety of immune cells, specialized in recognition of the Fc part of immunoglobulin G (IgG) …

SARS-CoV-2 induced a pandemic that is reported to have started in Asia and was then
extended to other countries in the world. Main clinical aspects of this viral infection have …

The 4Ts and HIT-Expert Probability (HEP) scoring tools for heparin-induced
thrombocytopenia (HIT) have not been validated in cardiac surgery patients, and the …

Heparin-induced thrombocytopenia (HIT) antibodies (Abs) can mediate and activate blood
cells, forming blood clots. To detect HIT Abs, immunological assays with high sensitivity (≥ …